Zobrazeno 1 - 10
of 71
pro vyhledávání: '"H Schnaper"'
Publikováno v:
Journal of Investigative Dermatology. 139:S166
Publikováno v:
Clinical Pediatric Nephrology, Second Edition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9da4c574071fcd3a51b9804a3386211
https://doi.org/10.3109/9780203482308-2
https://doi.org/10.3109/9780203482308-2
Publikováno v:
Clinical Pediatric Nephrology, Second Edition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::638c7b52632075457312682784a9b8ca
https://doi.org/10.3109/9780203482308-6
https://doi.org/10.3109/9780203482308-6
Publikováno v:
Clinical Pediatric Nephrology, Second Edition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56ae8895c1e8395015ea6adb015c2dec
https://doi.org/10.3109/9780203482308-24
https://doi.org/10.3109/9780203482308-24
Publikováno v:
Clinical Pediatric Nephrology, Second Edition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53c5bb980e4072f0ec9109562bb81ab7
https://doi.org/10.3109/9780203482308
https://doi.org/10.3109/9780203482308
Autor:
L M, Prisant, M, Downton, L O, Watkins, H, Schnaper, R H, Bradford, A N, Chremos, A, Langendörfer
Publikováno v:
The American journal of cardiology. 78(4)
A paucity of substantive data from clinical drug trials is available specifically evaluating the effects of therapy for hypercholesterolemia in African-Americans, even though a substantial number are candidates for medical advice and intervention for
Autor:
S. Banai, O. Hadjiconti, G. Karakiulakis, B. R. Unsworth, G. C. Haralabopoulos, Hela Gitay-Goren, A. Itin, Judith A. Berliner, D. S. Grant, H. Brem, D. E. Morales, E. Missirli, M. Bastaki, E. Keshet, E. Bacharach, Tzafra Cohen, Cliff Stevens, D. Bhartiya, Gera Neufeld, James Bready, Tulin Sahinoglu, D. Shweiki, Suzanne Harley, S. Maheshwari, D. Tsakayannis, M. Lehmann, I. Gresser, Anne Eichman, A. Budson, Bruce I. Terman, B. Klapthor, Maureen Dougher-Vermazen, Frank Arnold, Jozef Kaluza, Mark Fisher, George C. Haralabopoulos, Nicole M. LeDouarin, Nam D. Tran, C. van Ackern, I. Demopoulos, S. Papaioannou, C. Zurcher, M. E. Maragoudakis, V. W. M. van Hinsbergh, Eva Pipili-Synetos, E. Papadimitriou, W. H. Schnaper, Denis Gospodarowicz, F. Steinberg, Rajdip Marok, P. Rooney, Ben-Zion Levi, Vicky L.Y. Wong, G. Tamavokopulis, P. I. Lelkes, George Cherry, Nikos E. Tsopanoglou, Christophe Marcelle, Christiane Bréant, Jerzy Krupinski, M. C. Cid, P. Koolwijk, H. K. Kleinman, W. J. A. de Vree, M. A. Konerding, J. Folkman, Stewart Abbot, David Blake, I. Smith, S. Kumar
Publikováno v:
Angiogenesis ISBN: 9781475791907
The propensity of tumours to generate resistant clones is a major barrier to cytotoxic and hormone therapy. The vasculature of malignancies is a more appealing target, since tumour endothelial cells are not known to be tranformed or subject to somati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::021c75645a01fe5365c32677ccea3006
https://doi.org/10.1007/978-1-4757-9188-4_37
https://doi.org/10.1007/978-1-4757-9188-4_37
Autor:
James L. Pool, Sandra S. Stinnett, C Dujovne, A N Chremos, C L Shear, R H Bradford, H Schnaper, M Downton
Publikováno v:
Hypertension (Dallas, Tex. : 1979). 19(3)
Hypertension and hypercholesterolemia frequently coexist and may require concomitant drug treatments. The efficacy and safety profile of lovastatin given in the presence of antihypertensive medication was evaluated using patient subgroups identified
Autor:
W B, Applegate, H L, Phillips, H, Schnaper, A M, Shepherd, D, Schocken, J C, Luhr, G G, Koch, G D, Park
Publikováno v:
Archives of internal medicine. 151(9)
We conducted a multicenter, randomized, double-blind, parallel group trial to compare the impact of titrated doses of atenolol (50 to 100 mg once a day), enalapril (5 to 20 mg once a day), and diltiazem (sustained release) (60 to 180 mg twice a day)
Autor:
H. Schnaper, A. A. Carr, B. Brockway, Alexander M. M. Shepherd, M T Velasquez, L M Gonasun, J. Hamilton, M. Davidov, B. Hamilton, L. M. Prisant
Publikováno v:
Journal of Cardiovascular Pharmacology. 13:580-585
Of the calcium channel blocking drugs, only verapamil is approved in the United States for treatment of hypertension. Isradipine is a 1,4-dihydropyridine calcium blocker that may be given on a twice-daily basis. It causes peripheral vasodilation with